Table 2.
Patients with BD and BCS (n = 14) | |
---|---|
Additional etiologic factors, n (%) | 5 (38.5%) |
Antiphospholipid antibodies | 2 |
Hyperhomocyteinemia | 2 |
Factor II heterozygous gene mutation | 1 |
Associated venous thrombosis, n (%) | |
Pulmonary embolism | 7 (50%) |
Intracardiac [right atrium/right ventricle] | 5 (36%) [29%/7%] |
Superior vena cava | 3 (21%) |
Lower limbs | 4 (29%) |
Cerebral | 1 (7%) |
Abbreviations: BCS Budd-Chiari Syndrome, BD Behcet’s disease.